![Javier San Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Javier San Martin
Teknisk/Vetenskaplig/F&U Direktör på
LEONABIO, INC.
Förmögenhet: 112 162 $ per 2026-07-31
Profil
Javier San Martin is currently Chief Medical Officer at LeonaBio, Inc. since 2024.
Former positions include Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. from 2019 to 2024, Senior VP & Head-Global Clinical Development at Ultragenyx Pharmaceutical, Inc. from 2013 to 2019, Executive Director-Bone Therapeutic Area at Amgen, Inc., Principal at Eli Lilly & Co., and Senior Vice President-Clinical Development at Lundbeck Seattle BioPharmaceuticals, Inc. Education includes a doctorate from the University of Buenos Aires School of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
LEONABIO, INC. 0,17 % | 2026-05-01 | 15 887 ( 0,17 % ) | 112 162 $ | 2026-07-31 |
Aktiva positioner av Javier San Martin
| Företag | Position | Start |
|---|---|---|
| LEONABIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-04-15 |
Tidigare kända positioner av Javier San Martin
| Företag | Position | Slut |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-02-01 |
| ULTRAGENYX PHARMACEUTICAL INC. | Företagsledare/Principal | 2019-11-01 |
| AMGEN INC. | Företagsledare/Principal | - |
| ELI LILLY AND COMPANY | Företagsledare/Principal | - |
| ALDER BIOPHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Javier San Martins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
66
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
University of Buenos Aires School of Medicine
 University of Buenos Aires School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
